PMA P830063S015

Device
Prismaflex TPE2000 Set
Applicant
Vantive US Healthcare, LLC
PMA number
P830063
Supplement
S015
Product code
MDP
Decision date
2020-03-25
Generic name
Separator for therapeutic purposes, membrane automated blood cell/plasma
Approval order statement
Approval for the following changes in the instructions for use:1) A labeling change to align the sterile symbol to current sterile fluid path description in the instructions for use of the Prismaflex TPE2000 set; and2) The addition of the following warning statement: Use only drugs compatible with plastics listed in the specifications section. Some plastics can be incompatible with drugs when in contact with solutions with pH > 10.

Current openFDA PMA Record#

Device
Prismaflex TPE2000 Set
Applicant
Vantive US Healthcare, LLC
PMA number
P830063
Supplement
S015
Product code
MDP
Generic name
Separator for therapeutic purposes, membrane automated blood cell/plasma
Decision date
2020-03-25
Decision code
APPR
Date received
2020-02-24
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
Approval for the following changes in the instructions for use:1) A labeling change to align the sterile symbol to current sterile fluid path description in the instructions for use of the Prismaflex TPE2000 set; and2) The addition of the following warning statement: Use only drugs compatible with plastics listed in the specifications section. Some plastics can be incompatible with drugs when in contact with solutions with pH > 10.